Detalhe da pesquisa
1.
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
J Hepatol
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521170
2.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483300
3.
Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.
Liver Int
; 44(2): 286-292, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38131512
4.
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis.
Liver Int
; 44(2): 279-285, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100141
5.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
J Hepatol
; 79(2): 576-580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030400
6.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863683
7.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762906
8.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 118(9): 1601-1608, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719174
9.
Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test-and-treat program.
J Med Virol
; 95(2): e28544, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727653
10.
Low risk of viral hepatitis amongst patients with severe mental disorders.
Liver Int
; 43(6): 1204-1212, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041668
11.
Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response.
Liver Int
; 43(9): 1984-1994, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443448
12.
Benefits of using exchangeable copper and the ratio of exchangeable copper in a real-world cohort of patients with Wilson disease.
J Inherit Metab Dis
; 46(5): 982-991, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254446
13.
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver.
Rev Esp Enferm Dig
; 115(3): 128-132, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514974
14.
Clinical practice guidelines of the Catalan Society of Gastroenterology about hepatic elastography 2022. / Documento de posicionamiento de la «Societat Catalana de Digestologia¼ sobre elastografía hepática 2022.
Gastroenterol Hepatol
; 46(9): 732-746, 2023 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36435378
15.
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction. / Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica.
Gastroenterol Hepatol
; 46(2): 150-162, 2023 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36257502
16.
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Gastroenterol Hepatol
; 46(10): 764-773, 2023 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36731726
17.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut
; 71(3): 593-604, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741640
18.
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.
J Hepatol
; 76(4): 874-882, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856322
19.
Non-invasive tests for clinically significant portal hypertension after HCV cure.
J Hepatol
; 77(6): 1573-1585, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063968
20.
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.
Clin Gastroenterol Hepatol
; 20(10): 2276-2286.e6, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688952